Form 4 for AVIR Atea Pharmaceuticals, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-31 · accession 0001193125-26-036270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +58.0K | 141.8K | +69% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | F - Tax | $4.24 | -14.1K | 127.7K | -10% | -$59.9K |
| DM | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | M - OptEx | $0.00 | -58.0K | 0 | -100% | $0 |
| D | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | A - Grant | $0.00 | +177.0K | 177.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-31 | M | A | 58,050 | — | 141,801 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Includes 2,363 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-01-31 | F | D | 14,136 | $4.24 | 127,665 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 11,250 | $0.00 | 0 | D | — · — to — | 11,250 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
| 4 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 46,800 | $0.00 | 0 | D | — · — to — | 46,800 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) The original grant of 140,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-01-31 | A | A | 177,000 | $0.00 | 177,000 | D | $4.24 · — to 2036-01-30 | 177,000 Common Stock | (F5) The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030. |